Interpace Diagnostics Announces New York State Approval

Apr 23, 2019

Interpace Diagnostics Announces New Coverage of Thyroid Testing by Medica

Apr 2, 2019

Interpace Diagnostics Group Reports Full Year and Fourth Quarter 2018 Financial Results

Mar 19, 2019

Interpace Diagnostics Receives Regional Award as 2018 Top Life Sciences Company

Mar 4, 2019

Interpace Diagnostics Announces Preliminary 2018 Revenues

Feb 28, 2019

Interpace Diagnostics Announces First Independent Publication Demonstrating Clinical Utility of BarreGEN®

Feb 19, 2019

Interpace Diagnostics to Attend BIO CEO & Investor Conference in New York City

Feb 4, 2019

Interpace Diagnostics Announces Closing of $7.0 Million Public Offering of Common Stock

Jan 29, 2019

Interpace Diagnostics Announces Pricing of $7.0 Million Public Offering of Common Stock

Jan 25, 2019

Interpace Diagnostics Announces Proposed Public Offering of Common Stock

Jan 24, 2019